Literature DB >> 24694802

A subtype prediction score for primary aldosteronism.

K Nanba1, M Tsuiki1, K Nakao1, A Nanba1, T Usui1, T Tagami1, Y Hirokawa2, H Okuno3, T Suzuki4, T Shimbo4, A Shimatsu1, M Naruse1.   

Abstract

Primary aldosteronism (PA) is the most common cause of endocrine hypertension. Although adrenal venous sampling (AVS) is recommended as the gold standard procedure for subtype classification in PA, it is a specialized technique with limited availability. The objective of this study was to develop a scoring system that predicted PA subtype using clinical characteristics. Seventy-one patients with PA were studied. The subjects were diagnosed as having either unilateral (n=32) or bilateral disease (n=39) based on AVS, surgery and/or the postoperative clinical course. Variables associated with laterality in the univariate analysis were entered into multivariable logistic regression models and the regression coefficients were used to construct a subtype prediction score. The diagnostic significance of the score was then evaluated using receiver operating characteristic (ROC) curve analysis. The subtype prediction score was calculated as follows: serum potassium ⩽3.4 mEq l(-1), 2 points; plasma aldosterone concentration ⩾165 pg ml(-1), 3 points; and aldosterone to renin ratio ⩾1000 in a post-captopril challenge test (plasma renin activity in ng ml(-1) h(-1)), 3 points. ROC curve analysis for the ability to discriminate between unilateral and bilateral PA showed that a score of 5 points had 75% sensitivity and 95% specificity, and a score of 3 points had a sensitivity of 97% and a specificity of 59%. The area under the ROC curve was 0.920 (95% confidence interval, 0.859-0.979). Our subtype prediction score could discriminate between unilateral and bilateral PA and is useful for selecting patients who should undergo AVS before surgery.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24694802     DOI: 10.1038/jhh.2014.20

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  24 in total

1.  Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjects.

Authors:  Yuji Ito; Ryoyu Takeda; Shigehiro Karashima; Yasuhiro Yamamoto; Takashi Yoneda; Yoshiyu Takeda
Journal:  Hypertens Res       Date:  2010-10-07       Impact factor: 3.872

2.  Hyperaldosteronism among black and white subjects with resistant hypertension.

Authors:  David A Calhoun; Mari K Nishizaka; Mohammad A Zaman; Roopal B Thakkar; Paula Weissmann
Journal:  Hypertension       Date:  2002-12       Impact factor: 10.190

3.  Identification and implications of new types of mineralocorticoid hypertension.

Authors:  E G Biglieri; I Irony; C E Kater
Journal:  J Steroid Biochem       Date:  1989-01       Impact factor: 4.292

4.  Iodomethylnorcholesterol uptake in an aldosteronoma shown by dexamethasone-suppression scintigraphy: relationship to adenoma size and functional activity.

Authors:  K Nomura; K Kusakabe; M Maki; Y Ito; M Aiba; H Demura
Journal:  J Clin Endocrinol Metab       Date:  1990-10       Impact factor: 5.958

5.  The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism.

Authors:  Gian Paolo Rossi; Marlena Barisa; Bruno Allolio; Richard J Auchus; Laurence Amar; Debbie Cohen; Christoph Degenhart; Jaap Deinum; Evelyn Fischer; Richard Gordon; Ralph Kickuth; Gregory Kline; Andre Lacroix; Steven Magill; Diego Miotto; Mitsuhide Naruse; Tetsuo Nishikawa; Masao Omura; Eduardo Pimenta; Pierre-François Plouin; Marcus Quinkler; Martin Reincke; Ermanno Rossi; Lars Christian Rump; Fumitoshi Satoh; Leo Schultze Kool; Teresa Maria Seccia; Michael Stowasser; Akiyo Tanabe; Scott Trerotola; Oliver Vonend; Jiri Widimsky; Kwan-Dun Wu; Vin-Cent Wu; Achille Cesare Pessina
Journal:  J Clin Endocrinol Metab       Date:  2012-03-07       Impact factor: 5.958

6.  Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn's adenomas.

Authors:  Timothy J Burton; Isla S Mackenzie; Kottekkattu Balan; Brendan Koo; Nick Bird; Dmitri V Soloviev; Elena A B Azizan; Franklin Aigbirhio; Mark Gurnell; Morris J Brown
Journal:  J Clin Endocrinol Metab       Date:  2011-11-23       Impact factor: 5.958

7.  Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009.

Authors:  Tetsuo Nishikawa; Masao Omura; Fumitoshi Satoh; Hirotaka Shibata; Katsutoshi Takahashi; Naohisa Tamura; Akiyo Tanabe
Journal:  Endocr J       Date:  2011-08-09       Impact factor: 2.349

8.  Confirmatory testing in primary aldosteronism.

Authors:  Kazutaka Nanba; Tamiko Tamanaha; Kanako Nakao; Sachiko-Tsukamoto Kawashima; Takeshi Usui; Tetsuya Tagami; Hiroshi Okuno; Akira Shimatsu; Tomoko Suzuki; Mitsuhide Naruse
Journal:  J Clin Endocrinol Metab       Date:  2012-03-14       Impact factor: 5.958

9.  Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region.

Authors:  B Strauch; T Zelinka; M Hampf; R Bernhardt; J Widimsky
Journal:  J Hum Hypertens       Date:  2003-05       Impact factor: 3.012

Review 10.  Primary aldosteronism: part II: subtype differentiation and treatment.

Authors:  G P Rossi; T M Seccia; A C Pessina
Journal:  J Nephrol       Date:  2008 Jul-Aug       Impact factor: 3.902

View more
  11 in total

1.  Shortened saline infusion test for subtype prediction in primary aldosteronism.

Authors:  Kazutaka Nanba; Mika Tsuiki; Hironobu Umakoshi; Aya Nanba; Yuusuke Hirokawa; Takeshi Usui; Tetsuya Tagami; Akira Shimatsu; Tomoko Suzuki; Akiyo Tanabe; Mitsuhide Naruse
Journal:  Endocrine       Date:  2015-05-01       Impact factor: 3.633

2.  Significance of adrenal computed tomography in predicting laterality and indicating adrenal vein sampling in primary aldosteronism.

Authors:  K Kamemura; N Wada; T Ichijo; Y Matsuda; Y Fujii; T Kai; T Fukuoka; R Sakamoto; A Ogo; T Suzuki; H Umakoshi; M Tsuiki; M Naruse
Journal:  J Hum Hypertens       Date:  2016-09-01       Impact factor: 3.012

3.  Should Adrenal Venous Sampling Be Performed in PA Patients Without Apparent Adrenal Tumors?

Authors:  Kentaro Okamoto; Youichi Ohno; Masakatsu Sone; Nobuya Inagaki; Takamasa Ichijo; Takashi Yoneda; Mika Tsuiki; Norio Wada; Kenji Oki; Kouichi Tamura; Hiroki Kobayashi; Shoichiro Izawa; Akiyo Tanabe; Mitsuhide Naruse
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-12       Impact factor: 5.555

4.  Diagnostic Accuracy of Computed Tomography in Predicting Primary Aldosteronism Subtype According to Age.

Authors:  Seung Hun Lee; Jong Woo Kim; Hyun-Ki Yoon; Jung-Min Koh; Chan Soo Shin; Sang Wan Kim; Jung Hee Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2021-03-31

5.  Outcome-Based Decision-Making Algorithm for Treating Patients with Primary Aldosteronism.

Authors:  Jung Hee Kim; Chang Ho Ahn; Su Jin Kim; Kyu Eun Lee; Jong Woo Kim; Hyun-Ki Yoon; Yu-Mi Lee; Tae-Yon Sung; Sang Wan Kim; Chan Soo Shin; Jung-Min Koh; Seung Hun Lee
Journal:  Endocrinol Metab (Seoul)       Date:  2022-04-14

6.  Validation of three novel clinical prediction tools for primary aldosteronism subtyping.

Authors:  Tomaž Kocjan; Gaj Vidmar; Peter Popović; Milenko Stanković
Journal:  Endocr Connect       Date:  2022-05-11       Impact factor: 3.221

7.  Adrenal Venous Sampling Could Be Omitted before Surgery in Patients with Conn's Adenoma Confirmed by Computed Tomography and Higher Normal Aldosterone Concentration after Saline Infusion Test.

Authors:  Robert Holaj; Petr Waldauf; Dan Wichterle; Jan Kvasnička; Tomáš Zelinka; Ondřej Petrák; Zuzana Krátká; Lubomíra Forejtová; Jan Kaván; Jiří Widimský
Journal:  Diagnostics (Basel)       Date:  2022-07-15

8.  Determination of adrenal hypersecretion in primary Aldosteronism without aldosterone-production adenomas.

Authors:  Fang Sun; Yangning Hong; Hexuan Zhang; Xiaoli Liu; Zhigang Zhao; Hongbo He; Zhencheng Yan; Zhiming Zhu
Journal:  BMC Endocr Disord       Date:  2021-05-31       Impact factor: 2.763

9.  A clinical prediction score for diagnosing unilateral primary aldosteronism may not be generalizable.

Authors:  Erik S Venos; Benny So; Valerian C Dias; Adrian Harvey; Janice L Pasieka; Gregory A Kline
Journal:  BMC Endocr Disord       Date:  2014-12-11       Impact factor: 2.763

10.  A case of primary aldosteronism with resistant hypertension successfully treated by unilateral adrenalectomy after unsuccessful classification of subtype in adrenal venous sampling.

Authors:  Ryo Nakamaru; Koichi Yamamoto; Satoko Nozato; Kazuhiro Hongyo; Motonori Nagasawa; Hideharu Hagiya; Futoshi Nakagami; Hiroshi Akasaka; Hitomi Kurinami; Yoichi Takami; Yasushi Takeya; Ken Sugimoto; Takeshi Ujike; Motohide Uemura; Norio Nonomura; Hiromi Rakugi
Journal:  Clin Case Rep       Date:  2019-08-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.